Inozyme Pharma, Inc. (INZY)
NASDAQ: INZY · Real-Time Price · USD
2.690
-0.100 (-3.58%)
Nov 21, 2024, 4:00 PM EST - Market closed
Inozyme Pharma Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 173 | 263 | 42 | 161 | 482 | - | |
| Market Cap Growth | 26.55% | 520.31% | -73.72% | -66.54% | - | - | |
| Enterprise Value | 88 | 105 | -92 | 40 | 323 | - | |
| Last Close Price | 2.69 | 4.26 | 1.05 | 6.82 | 20.64 | - | |
| PB Ratio | 2.09 | 1.87 | 0.36 | 1.48 | 3.05 | - | |
| P/TBV Ratio | 3.96 | 1.87 | 0.36 | 1.48 | 3.05 | - | |
| Debt / Equity Ratio | 0.57 | 0.33 | 0.06 | 0.03 | - | - | |
| Quick Ratio | 7.17 | 12.87 | 8.70 | 9.62 | 14.83 | 14.60 | |
| Current Ratio | 7.68 | 13.36 | 8.93 | 9.92 | 15.14 | 14.67 | |
| Return on Equity (ROE) | -79.42% | -54.98% | -58.91% | -42.36% | -55.64% | -45.94% | |
| Return on Assets (ROA) | -35.69% | -27.81% | -32.67% | -24.17% | -32.81% | -28.43% | |
| Return on Capital (ROIC) | -38.46% | -30.28% | -36.10% | -26.15% | -35.16% | -30.29% | |
| Earnings Yield | -55.84% | -27.05% | -158.11% | -35.08% | -11.70% | - | |
| FCF Yield | -52.87% | -26.98% | -137.15% | -30.08% | -7.57% | - | |
| Buyback Yield / Dilution | -31.49% | -37.27% | -60.30% | -113.46% | -832.81% | -12.60% | |
| Total Shareholder Return | -31.49% | -37.27% | -60.30% | -113.46% | -832.81% | -12.60% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.